|1.||Ouwehand, Arthur C: 3 articles (01/2014 - 06/2010)|
|2.||Blaak, Ellen E: 2 articles (07/2015 - 01/2014)|
|3.||Kalliomäki, Marko: 2 articles (02/2014 - 11/2013)|
|4.||Isolauri, Erika: 2 articles (02/2014 - 11/2013)|
|5.||Salminen, Seppo: 2 articles (02/2014 - 11/2013)|
|6.||Luoto, Raakel: 2 articles (02/2014 - 11/2013)|
|7.||Mäkivuokko, Harri: 2 articles (11/2011 - 01/2005)|
|8.||Rautonen, Nina: 2 articles (11/2011 - 01/2005)|
|9.||Carroccio, Antonio: 1 article (10/2015)|
|10.||Seidita, Aurelio: 1 article (10/2015)|
|1.||Body Weight (Weight, Body)
01/14/2014 - "The objective of the present study was to investigate whether replacement of 30 % of the available carbohydrates with polydextrose (PDX) or soluble maize fibre (SCF) at breakfast and lunch would result in an increased fat oxidation rate and satiety, which may be of relevance for body weight control and diabetes prevention. "
07/01/2015 - "The role of polydextrose in body weight control and glucose regulation."
03/01/1987 - "Polydextrose had no significant effects on food intake, body-weight gain, digestibility of nitrogen and N retention but significantly increased the water consumption to 143% of the control value (P less than 0.05) and the water content of fresh faecal pellets from 548 (SE 10) to 646 (SE 15) g/kg wet weight (P less than 0.01). "
07/01/2009 - "Polydextrose mimicked other prebiotic carbohydrates and had no adverse effect at the highest tested level 17.0 g PDX/L, equivalent to a dose of 8.35 g/kg of body weight per day."
05/01/1998 - "at a dimethylhydrazine (DMH) dose 10 mg/kg body weight once weekly for 10 weeks with or without dietary supplementation with 3% polydextrose, lactosucrose or cellulose, or 3% polydextrose and 3% cellulose in combination. "
01/01/2014 - "Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation."
01/01/2015 - "Effect of Polydextrose Intake on Constipation in Japanese Dialysis Patients: A Triple-Blind, Randomized, Controlled Trial."
|3.||Colonic Neoplasms (Colon Cancer)
01/01/2005 - "In vitro modulation of COX expression by colon microbial fermentation products of polydextrose offers an interesting starting point for further studies on possible risk-decreasing effect of PDX on the development of colon cancer."
01/01/2005 - "A 4-stage colon simulator and a cell culture-based human intestinal epithelial function model were combined to study the effects of a soluble fiber, polydextrose (PDX), on intestinal microbes and mucosal functions relevant to the risk of colon cancer. "
11/01/2011 - "Furthermore, up-regulated effects on classes linked with apoptosis, with increased caspase 2 and 3 activity, implicate that polydextrose fermentation plays a role in induction of apoptosis in colon cancer cells. "
|4.||Birth Weight (Birth Weights)
11/01/2013 - "Ninety-four preterm infants (gestational age 32-36 weeks and birth weight >1500 g) randomized to receive prebiotics (mixture of galacto-oligosaccharide and polydextrose 1:1), probiotics (Lactobacillus rhamnosus GG), or placebo during the first 2 months of life were followed up for 1 year. "
02/01/2014 - "In this randomized, double-blind, placebo-controlled trial (ClinicalTrials.gov no. NCT00167700), 94 preterm infants (gestational age, ≥32 + 0 and ≤36 + 6 weeks; birth weight, >1500 g) treated at Turku University Hospital, Turku, Finland, were allocated to receive oral prebiotics (galacto-oligosaccharide and polydextrose mixture, 1:1), a probiotic (Lactobacillus rhamnosus GG, ATCC 53103), or placebo (microcrystalline cellulose) between days 3 and 60 of life. "
12/01/2010 - "Because sulfasalazine presents serious side effects through long-term use at high doses, the aim of the present study was to evaluate the preventative effect of polydextrose on trinitrobenzenesulfonic acid-induced intestinal inflammation and its effects on the intestinal anti-inflammatory activity of sulfasalazine. "
|3.||Neurotransmitter Agents (Neurotransmitter)